B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids.
Ferraccioli, GianFranco
B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids. [electronic resource] - Acta diabetologica Sep 2008 - 195-6 p. digital
Publication Type: Case Reports; Letter
1432-5233
10.1007/s00592-008-0036-9 doi
Adult
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antirheumatic Agents--therapeutic use
B-Lymphocytes--pathology
Combined Modality Therapy
Cyclosporine--therapeutic use
Diabetes Mellitus, Type 1--complications
Drug Delivery Systems
Female
Humans
Immunosuppression Therapy--methods
Immunosuppressive Agents--therapeutic use
Leukapheresis--methods
Lupus Erythematosus, Systemic--complications
Rituximab
T-Lymphocytes--drug effects
Treatment Outcome
B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids. [electronic resource] - Acta diabetologica Sep 2008 - 195-6 p. digital
Publication Type: Case Reports; Letter
1432-5233
10.1007/s00592-008-0036-9 doi
Adult
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antirheumatic Agents--therapeutic use
B-Lymphocytes--pathology
Combined Modality Therapy
Cyclosporine--therapeutic use
Diabetes Mellitus, Type 1--complications
Drug Delivery Systems
Female
Humans
Immunosuppression Therapy--methods
Immunosuppressive Agents--therapeutic use
Leukapheresis--methods
Lupus Erythematosus, Systemic--complications
Rituximab
T-Lymphocytes--drug effects
Treatment Outcome